Ultra Long Acting Insulin Degludec Reduces Nocturnal Hypoglycemia

An investigational compound from Novo Nordisk, significantly reduces the rates of nocturnal hypoglycemia by 25%, compared to insulin glargine.
An investigational compound from Novo Nordisk, significantly reduces the rates of nocturnal hypoglycemia by 25%, compared to insulin glargine.
Bayer HealthCare today announced that the U.S. Food and Drug Administration (FDA) has cleared its CONTOUR® Next EZ, a new blood glucose monitoring (BGM) system for use in the United States.
Nearly 20 percent of men with sexual dysfunction have impaired fasting glucose and are more likely than men with normal glucose levels to have severe erectile dysfunction.
Doctors are more reluctant to start their patients on insulin than the patients are themselves, according to a new study led by researchers at St. Michael’s Hospital.
A Diabetes Health reader writes in to ask: Is there a generic alternative to Humalog insulin? If so, what is its cost compared to Humalog?
Insulin administration has traditionally been one of the last steps in the treatment of type 2 diabetes mellitus (T2DM), but that’s changing.
Research shows that people with Type 1 and Type 2 diabetes who regularly self-monitor their blood glucose levels can achieve better glycaemic control. It can be very difficult to maintain and the iBGStar aims to make it easier to self-monitor and gain control.
An innovative company called PositiveID Corporation is developing three new products that could drastically improve the world of diabetes management.
THE majority of diabetics who check their glucose levels at home do not understand how to monitor themselves properly and take no action when readings are abnormal.
The first blood glucose monitor to seamlessly connect to the Apple iPhone and iPod touch has been launched.
A new device launched in the UK will enable diabetics to manage their condition with a smartphone.
Forget about Y2K – this year’s Leap Year date of Feb. 29, 2012, caused a hiccup in the Animas OneTouch Ping system that the company wants to alert customers to right away.
Medtronic is reporting successful results from an in-clinic study of its the MiniMed Paradigm System featuring Low Glucose Suspend (LGS) in diabetics who are subject to having bouts of hypoglycemia.
Medtronic Inc. has asked software-security experts to investigate the safety of its insulin pumps, as a new claim surfaced that at least one of its devices could be hacked to dose diabetes patients with potentially lethal amounts of insulin.
If you’re a diabetic, you know how painful it is to prick your fingers every day in order to measure your blood sugar level. But there’s some research being done that could put an end to that, and it comes in the form of a tattoo.
Less than half of newly diagnosed patients with type 2 diabetes achieve A1C <7 percent, and those that do achieve it more likely started with lower A1C levels, according to a study published in the March issue of Diabetes Care.
A British diabetic has become the world’s first teenager to be fitted with an implant which could “cure” her condition.
Insulin pumps are to be offered free to everyone with Type 1 diabetes under the age of 18 in Scotland.
If a smartphone can be configured to perform a medical laboratory test, then why can’t some clinical lab tests be performed by an automobile? Believe it or not, several car companies are preparing to introduce these types of features into their automobiles in coming years.
Self-monitoring of blood sugar levels is a key part of managing type 1 and type 2 diabetes in patients treated with insulin. Yet, it is unclear if self-monitoring works for those not treated with insulin.